Skip to main content
Premium Trial:

Request an Annual Quote

MDMA, New Hampshire Contingent Join Opposition to Patent Reform Act

NEW YORK (GenomeWeb News) — The Medical Devices Manufacturers Association and a private-public New Hampshire-based contingent last week joined the growing list of organizations opposing the Patent Reform Act of 2007, currently under bi-cameral review in the US Congress.
 
In a letter sent to key members of the House and Senate Judiciary Committees, MDMA representatives said that the Act would “hinder innovation across the diverse sectors of the American economy we represent, including academia, agriculture, alternative energy, biotechnology, chemical, electronics, environmental technology, financial services, information technology, life sciences, nanotechnology, and telecommunications.”
 
The letter highlights three shared areas of concern: language pertaining to the apportionment of damages, the creation of an open-ended post-grant review process, and the granting of unprecedented rulemaking authority for the US Patent and Trademark Office.
 
Other signatories of the letter include the Biotechnology Industry Organization, Innovation Alliance, NanoBusiness Alliance, CropLife America, Association of University Technology Managers, Institute of Electrical and Electronics Engineers, Small Business Technology Council, and Center for Small Business and the Environment.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.